C07D 275/04
Condensed with carbocyclic rings or ring systems
Official title: condensed with carbocyclic rings or ring systems
C07D275/04 (Condensed with carbocyclic rings or ring systems) appears on 691 US grants and 386 published applications in this corpus.
Search patents in C07D- Granted patents
- 691
- Published applications
- 386
- Assignees
- 325
- Inventors
- 1,668
- Latest grant
- 26 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 9 | 0 |
| 1977 | 11 | 0 |
| 1978 | 12 | 0 |
| 1979 | 22 | 0 |
| 1980 | 20 | 0 |
| 1981 | 17 | 0 |
| 1982 | 4 | 0 |
| 1983 | 9 | 0 |
| 1984 | 8 | 0 |
| 1985 | 4 | 0 |
| 1986 | 15 | 0 |
| 1987 | 13 | 0 |
| 1988 | 18 | 0 |
| 1989 | 15 | 0 |
| 1990 | 9 | 0 |
| 1991 | 12 | 0 |
| 1992 | 15 | 0 |
| 1993 | 15 | 0 |
| 1994 | 12 | 0 |
| 1995 | 15 | 0 |
| 1996 | 46 | 0 |
| 1997 | 32 | 0 |
| 1998 | 24 | 0 |
| 1999 | 31 | 0 |
| 2000 | 19 | 0 |
| 2001 | 18 | 2 |
| 2002 | 11 | 9 |
| 2003 | 9 | 10 |
| 2004 | 6 | 16 |
| 2005 | 4 | 14 |
| 2006 | 8 | 26 |
| 2007 | 13 | 14 |
| 2008 | 12 | 13 |
| 2009 | 13 | 24 |
| 2010 | 9 | 20 |
| 2011 | 13 | 20 |
| 2012 | 16 | 19 |
| 2013 | 15 | 13 |
| 2014 | 17 | 18 |
| 2015 | 13 | 18 |
| 2016 | 11 | 17 |
| 2017 | 19 | 16 |
| 2018 | 12 | 21 |
| 2019 | 13 | 11 |
| 2020 | 11 | 13 |
| 2021 | 4 | 17 |
| 2022 | 9 | 14 |
| 2023 | 3 | 6 |
| 2024 | 12 | 13 |
| 2025 | 9 | 11 |
| 2026 | 4 | 11 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Histone deacetylase inhibitors26 May 2026US 12,637,433 B2The University of Queensland
- Process for preparing 1,2-benzisothiazoline-3-one19 May 2026US 12,630,518 B2Thor GmbH
- Substituted pyrrolo[3,4-b]pyridines as PI3K-α inhibitors17 Mar 2026US 12,581,252 B2D. E. Shaw Research, LLC
- Oral complement factor D inhibitors24 Feb 2026US 12,558,341 B2BioCryst Pharmaceuticals, Inc.
- Nitrosation reagents and methods4 Nov 2025US 12,459,909 B2The Regents of the University of California
- Bleach Catalyst and Composition Comprising Said Catalyst24 Sep 2026US 2026/0286254 A1Reckitt Benckiser Vanish B.V.
- Bleach Catalyst With Improved Performance, Granule Comprising The Bleach Catalyst, And Composition Comprising Said Catalyst Or Said Granule17 Sep 2026US 2026/0275249 A1Reckitt Benckiser Vanish B.V.
- Crystalline forms and formulations of a kras inhibitor3 Sep 2026US 2026/0258055 A1Eli Lilly and Company
- Compounds, compositions, and methods of use to inhibit protein aggregation6 Aug 2026US 2026/0224538 A1Purdue Research Foundation
- Pi3k-alpha inhibitors and methods of use thereof16 Jul 2026US 2026/0205746 A1D. E. Shaw Research, LLC
Most cited
By later US patents
- Cyclic amides171US 5,698,579 ACelgene Corporation · 1997
- Cyclic amides169US 5,877,200 ACelgene Corporation · 1999
- 4-Hydroxy-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxides and salts thereof142US 4,233,299 ABoehringer Ingelheim GmbH · 1980
- Substituted phenethylsulfones and method of reducing TNF.alpha. levels136US 6,020,358 ACelgene Corporation · 2000
- Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics115US 5,364,866 AHoechst-Roussel Pharmaceuticals Inc. · 1994